Advertisement
News
Subscribe to MDT Magazine News

New therapy found for lung and skin cancer, based on suicide gene E

September 21, 2010 12:31 pm | by EurekAlert | Comments

(University of Granada) This coliphage gene can induce death to cells transected with it. Scientists at the University of Granada have proven that this method is not only effective in vitro (using tumor cell cultures), but also in vivo, through the use of experimental animals in which...

TOPICS:

Data show clinical benefit from mitral valve clip device

September 21, 2010 11:36 am | by EurekAlert | Comments

(Cardiovascular Research Foundation) A percutaneous mitral valve clip designed to stop mitral valve regurgitation demonstrated clinical benefit as measured by the degree of mitral regurgitation, according to a study presented at the 22nd annual Transcatheter Cardiovascular...

TOPICS:

Study examines use of stent with bioabsorbable polymer

September 21, 2010 11:36 am | by EurekAlert | Comments

(Cardiovascular Research Foundation) Three-year data demonstrated that satisfactory clinical and safety outcomes of sirolimus eluting stents with a biodegradable polymer were sustained in a real world setting. The results were presented at the 22nd annual Transcatheter...

TOPICS:
Advertisement

TI introduces power converter for energy harvesting and low-power applications

September 21, 2010 11:36 am | by I-Micronews | Comments

Texas Instruments Inc. (TI) introduced a high-efficiency, ultra-low power step-down converter for energy harvesting and low-power applications.

Mitsubishi Chemical to add MOCVD Systems for LEDs with $175 million investment

September 21, 2010 11:36 am | by I-Micronews | Comments

Mitsubishi plans to invest 15 billion yen (US$175 million) in MOCVD systems for high brightness LED production, according to an article in the Nikkei newspaper.

Tamar Technology receives orders for its TSV measurement technology

September 21, 2010 11:36 am | by I-Micronews | Comments

Tamar Technology received orders from two major semiconductor equipment manufacturers for its Through-Silicon Via (TSV) measurement technology.

Agios appoints Novartis vet Biller as CSO

September 21, 2010 11:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Agios Pharmaceuticals Inc., a Cambridge biotech focused on cancer metabolism-based therapeutics, has named Novartis veteran Scott Biller as chief scientific officer.

Holy Redeemer Partners with MobileMD to Deliver Health Information Exchange Services to Care Community

September 21, 2010 11:34 am | by Bio-Medicine.Org | Comments

WARMINSTER and HUNTINGDON VALLEY, Pa., Sept. 21 /- MobileMD, Warminster, and Holy Redeemer Health System, Huntingdon Valley, announced today an agreement to provide state-of-the-art Health Information Exchange (HIE) services to Holy Redeemer and its entire healthcare provider community....

TOPICS:
Advertisement

Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015

September 21, 2010 11:34 am | by Bio-Medicine.Org | Comments

TORONTO, Sept. 21 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the introduction and adoption of new growth factors, combined with greater variety and improved features of newer products, will drive the US bone graft...

TOPICS:

New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed

September 21, 2010 11:32 am | by Bio-Medicine.Org | Comments

STOCKHOLM, Sept. 21 /- More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77 percent of physicians estimate that in reality this number could be as high as six...

TOPICS:

ImmunoGen begins clinical tests of cancer treatment

September 21, 2010 11:32 am | by Mass High Tech: The Journal of New England Technology | Comments

ImmunoGen Inc. has begun clinical testing of its drug candidate SAR566658, co-developed with Paris pharmaceutical giant Sanofi-aventis, in treating ovarian, breast, cervical, lung and pancreatic cancers.

TOPICS:

The AACR to Host Molecular Diagnostics Conference

September 21, 2010 11:32 am | by AACR | Comments

DENVER — The American Association for Cancer Research will host its Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development from Sept. 27-30, 2010, at the Sheraton Denver Downtown in Denver, Colo.

TOPICS:

TSX-listed corporate dividends and distributions declared Sept. 21, 2010

September 21, 2010 10:45 am | by The Associated Press | Comments

Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on September 21, 2010.Claymore Canadian Fundamental Index Etf Units (TSX:CRQ): $0.06. Payable Jul 07. Record Jun 29.Claymore Bric Etf Units (TSX:CBQ): $0.035. Payable Jul 07. Record...

Solos Endoscopy, Inc. to Hold Annual Shareholder Meeting September 28, 2010

September 21, 2010 10:32 am | by Bio-Medicine.Org | Comments

BOSTON, Sept. 21 /- Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce that the Company will be holding its annual shareholder meeting on Tuesday, September 28, 2010 at 9:00am EDT. The meeting will be held at the Hilton of Boston/Dedham located at 25 Allied Drive, Dedham,...

TOPICS:

Boston Scientific stent gains extended approval

September 21, 2010 9:34 am | by Mass High Tech: The Journal of New England Technology | Comments

Boston Scientific Corp. today announced that one of its coronary stents, the Promus Element Everolimus-Eluting Coronary Stent System, has been approved for additional treatments of diabetes and heart attacks in the European economic community.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading